It is evident from the preceding discussion that LpPLA2 may engage with additional risk factors, particularly in individuals experiencing hyperglycemia and hyperlipemia, which together may contribute to the advancement of vascular diseases. This evidence concerns the gene PLA2G7 and Hyperglycemia.